Vanguard Personalized Indexing Management, LLC Rapt Therapeutics, Inc. Transaction History

Vanguard Personalized Indexing Management, LLC

$8.6 Billion
Q2 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 13, 2025	SELL	$1.05 - $1.72 $385 - $631	-367 Reduced 1.24%	29,290 $35,000
Q4 2024 Feb 10, 2025	BUY	$0.81 - $3.1 $24,022 - $91,936	29,657 New	29,657 $46,000

Others Institutions Holding RAPT

# of Institutions

Shares Held

6.5M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

2.44M
Shares

$71 Million
0.0% of portfolio
Ponoi Management, LLC San Francisco, CA

1.6M
Shares

$46.5 Million
52.54% of portfolio
Column Group LLC San Francisco, CA

1.33M
Shares

$38.7 Million
16.17% of portfolio
Kpcb Xv Associates, LLC

649K
Shares

$18.9 Million
43.54% of portfolio
Ponoi Ii Management, LLC San Francisco, CA

145K
Shares

$4.23 Million
9.14% of portfolio

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $863M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account